Abin-2 Polyclonal Antibody

Rabbit Anti-Abin-2 Polyclonal Antibody

Product Specifications

Background

TNIP2 encodes a protein which acts as an inhibitor of NFkappaB activation. The encoded protein is also involved in MAP/ERK signaling pathway in specific cell types. It may be involved in apoptosis of endothelial cells. Alternative splicing results in multiple transcript variants. A pseudogene related to TNIP2 is located on the X chromosome TNIP2 (TNFAIP3 Interacting Protein 2) is a Protein Coding gene. Among its related pathways are Ovarian tumor domain proteases and Activated TLR4 signalling.

CAS Number

9007-83-4

Product Name Alternative

TNFAIP3-interacting protein 2; A20-binding inhibitor of NF-kappa-B activation 2; ABIN-2; Fetal liver LKB1-interacting protein

Gene ID

79155

Accession Number

Q8NFZ5

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from part region of human Abin-2 protein at amino acid sequence of 61-110

Clonality

Polyclonal

Tag

Abin-2

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of Abin-2

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-200; ELISA 1:10000-20000; IF 1:50-200